1887

Abstract

Millions of intravaginal rings (IVRs) are used by women worldwide for contraception and for the treatment of vaginal atrophy. These devices also are suitable for local and systemic sustained release drug delivery, notably for antiviral agents in human immunodeficiency virus pre-exposure prophylaxis. Despite the widespread use of IVRs, no studies have examined whether surface-attached bacterial biofilms develop , an important consideration when determining the safety of these devices. The present study used scanning electron microscopy, fluorescence hybridization and confocal laser scanning microscopy to study biofilms that formed on the surface of IVRs worn for 28 days by six female pig-tailed macaques, an excellent model organism for the human vaginal microbiome. Four of the IVRs released the nucleotide analogue reverse transcriptase inhibitor tenofovir at a controlled rate and the remaining two were unmedicated. Large areas of the ring surfaces were covered with monolayers of epithelial cells. Two bacterial biofilm phenotypes were found to develop on these monolayers and both had a broad diversity of bacterial cells closely associated with the extracellular material. Phenotype I, the more common of the two, consisted of tightly packed bacterial mats approximately 5 µm in thickness. Phenotype II was much thicker, typically 40 µm, and had an open architecture containing interwoven networks of uniform fibres. There was no significant difference in biofilm thickness and appearance between medicated and unmedicated IVRs. These preliminary results suggest that bacterial biofilms could be common on intravaginal devices worn for extended periods of time.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.028225-0
2011-06-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/6/828.html?itemId=/content/journal/jmm/10.1099/jmm.0.028225-0&mimeType=html&fmt=ahah

References

  1. Abdool Karim Q., Abdool Karim S. S., Frohlich J. A., Grobler A. C., Baxter C., Mansoor L. E., Kharsany A. B. M., Sibeko S., Mlisana K. P. et al. 2010; Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168–1174 [View Article][PubMed]
    [Google Scholar]
  2. Amann R. I., Ludwig W., Schleifer K. H. 1995; Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 59:143–169[PubMed]
    [Google Scholar]
  3. Baum M. M., Kainović A., O’Keeffe T., Pandita R., McDonald K., Wu S., Webster P. 2009; Characterization of structures in biofilms formed by a Pseudomonas fluorescens isolated from soil. BMC Microbiol 9:103 [View Article][PubMed]
    [Google Scholar]
  4. Begley J. S., Barnes R. C. 2007; Group B streptococcus toxic shock-like syndrome in a healthy woman: a case report. J Reprod Med 52:323–325[PubMed]
    [Google Scholar]
  5. Camacho D. P., Consolaro M. E. L., Patussi E. V., Donatti L., Gasparetto A., Svidzinski T. I. E. 2007; Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Contraception 76:439–443 [View Article][PubMed]
    [Google Scholar]
  6. Chassot F., Negri M. F. N., Svidzinski A. E., Donatti L., Peralta R. M., Svidzinski T. I. E., Consolaro M. E. L. 2008; Can intrauterine contraceptive devices be a Candida albicans reservoir?. Contraception 77:355–359 [View Article][PubMed]
    [Google Scholar]
  7. Costerton J. W., Stewart P. S., Greenberg E. P. 1999; Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322 [View Article][PubMed]
    [Google Scholar]
  8. Costerton W., Veeh R., Shirtliff M., Pasmore M., Post C., Ehrlich G. 2003; The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466–1477[PubMed] [CrossRef]
    [Google Scholar]
  9. Davies D. 2003; Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114–122 [View Article][PubMed]
    [Google Scholar]
  10. Dezarnaulds G., Fraser I. S. 2003; Vaginal ring delivery of hormone replacement therapy – a review. Expert Opin Pharmacother 4:201–212 [View Article][PubMed]
    [Google Scholar]
  11. Geonnotti A. R., Katz D. F. 2010; Compartmental transport model of microbicide delivery by an intravaginal ring. J Pharm Sci 99:3514–3521 [View Article][PubMed]
    [Google Scholar]
  12. Gorby Y. A., Yanina S., McLean J. S., Rosso K. M., Moyles D., Dohnalkova A., Beveridge T. J., Chang I. S., Kim B. H. et al. 2006; Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganisms. Proc Natl Acad Sci U S A 103:11358–11363 [View Article][PubMed]
    [Google Scholar]
  13. Johnsen A. R., Hausner M., Schnell A., Wuertz S. 2000; Evaluation of fluorescently labeled lectins for noninvasive localization of extracellular polymeric substances in Sphingomonas biofilms. Appl Environ Microbiol 66:3487–3491 [View Article][PubMed]
    [Google Scholar]
  14. Lal P., Agarwal V., Pruthi P., Pereira B. M. J., Kural M. R., Pruthi V. 2008; Biofilm formation by Candida albicans isolated from intrauterine devices. Indian J Microbiol 48:438–444 [View Article]
    [Google Scholar]
  15. Macalady J. L., Lyon E. H., Koffman B., Albertson L. K., Meyer K., Galdenzi S., Mariani S. 2006; Dominant microbial populations in limestone-corroding stream biofilms, Frasassi cave system, Italy. Appl Environ Microbiol 72:5596–5609 [View Article][PubMed]
    [Google Scholar]
  16. Martín R., Suárez J. E. 2010; Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 76:400–405 [View Article][PubMed]
    [Google Scholar]
  17. Miller L., MacFarlane S. A., Materi H. L. 2005; A scanning electron microscopic study of the contraceptive vaginal ring. Contraception 71:65–67 [View Article][PubMed]
    [Google Scholar]
  18. Moss, J. A., Baum, M. M., Malone, A. M., Friend, D. R., Smith, J., Kopin, E., Kennedy, S., Nguyen, C., Cortez, C. & other authors (2010). In vitro release of tenofovir and acyclovir from a silicone vaginal ring platform. In: Abstracts of the International Microbicides Conference 2010, Pittsburgh, PA, USA, abstract 259. p. 153. Pittsburgh, PA: Microbicide Trials Network
  19. Nel A., Smythe S., Young K., Malcolm K., McCoy C., Rosenberg Z., Romano J. 2009; Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. J Acquir Immune Defic Syndr 51:416–423 [View Article][PubMed]
    [Google Scholar]
  20. NIH (1996). Guide for the Care and Use of Laboratory Animals, NIH publication no. 85-23. Washington, DC: National Institutes of Health
  21. Patton D. L., Sweeney Y. C., Rabe L. K., Hillier S. L. 1996; The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem. Sex Transm Dis 23:489–493 [View Article][PubMed]
    [Google Scholar]
  22. Patton D. L., Sweeney Y. T. C., Agnew K. J., Balkus J. E., Rabe L. K., Hillier S. L. 2006; Development of a nonhuman primate model for Trichomonas vaginalis infection. Sex Transm Dis 33:743–746 [View Article][PubMed]
    [Google Scholar]
  23. Promadej-Lanier N., Smith J. M., Srinivasan P., McCoy C. F., Butera S., Woolfson A. D., Malcolm R. K., Otten R. A. 2009; Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates. J Med Primatol 38:263–271 [View Article][PubMed]
    [Google Scholar]
  24. Rabe L. K., Hillier S. L. 2003; Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J Clin Microbiol 41:3260–3264 [View Article][PubMed]
    [Google Scholar]
  25. Romano J., Variano B., Coplan P., Van Roey J., Douville K., Rosenberg Z., Temmerman M., Verstraelen H., Van Bortel L. et al. 2009; Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res Hum Retroviruses 25:483–488 [View Article][PubMed]
    [Google Scholar]
  26. Romero R., Schaudinn C., Kusanovic J. P., Gorur A., Gotsch F., Webster P., Nhan-Chang C. L., Erez O., Kim C. J. et al. 2008; Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 198:135.e1–135.e5 [View Article][PubMed]
    [Google Scholar]
  27. Saxena B. B., Han Y. A., Fu D. Y., Rathnam P., Singh M., Laurence J., Lerner S. 2009; Sustained release of microbicides by newly engineered vaginal rings. AIDS 23:917–922 [View Article][PubMed]
    [Google Scholar]
  28. Schaudinn C., Stoodley P., Kainović A., O’Keeffe T., Costerton J. W., Robinson D. H., Baum M. M., Ehrlich G., Webster P. S. 2007; Bacterial biofilms, other structures seen as mainstream concepts. Microbe 2:231–237
    [Google Scholar]
  29. Smith D. J., Wakasiaka S., Hoang T. D. M., Bwayo J. J., Del Rio C., Priddy F. H. 2008; An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population. J Womens Health (Larchmt) 17:1025–1034 [View Article][PubMed]
    [Google Scholar]
  30. Spear G. T., Gilbert D., Sikaroodi M., Doyle L., Green L., Gillevet P. M., Landay A. L., Veazey R. S. 2010; Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retroviruses 26:193–200 [View Article][PubMed]
    [Google Scholar]
  31. Stewart P. S. 2002; Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292:107–113 [View Article][PubMed]
    [Google Scholar]
  32. Stoner K. A., Rabe L. K., Austin M. N., Meyn L. A., Hillier S. L. 2008; Quantitative survival of aerobic and anaerobic microorganisms in Port-A-Cul and Copan transport systems. J Clin Microbiol 46:2739–2744 [View Article][PubMed]
    [Google Scholar]
  33. Strathmann M., Wingender J., Flemming H. C. 2002; Application of fluorescently labelled lectins for the visualization and biochemical characterization of polysaccharides in biofilms of Pseudomonas aeruginosa . J Microbiol Methods 50:237–248 [View Article][PubMed]
    [Google Scholar]
  34. Swidsinski A., Mendling W., Loening-Baucke V., Ladhoff A., Swidsinski S., Hale L. P., Lochs H. 2005; Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106:1013–1023 [View Article][PubMed]
    [Google Scholar]
  35. Swidsinski A., Mendling W., Loening-Baucke V., Swidsinski S., Dörffel Y., Scholze J., Lochs H., Verstraelen H. 2008; An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 198:97.e1–97.e6 [View Article][PubMed]
    [Google Scholar]
  36. Tang Y. W., Himmelfarb E., Wills M., Stratton C. W. 2010; Characterization of three Staphylococcus aureus isolates from a 17-year-old female who died of tampon-related toxic shock syndrome. J Clin Microbiol 48:1974–1977 [View Article][PubMed]
    [Google Scholar]
  37. Valenta C. 2005; The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev 57:1692–1712 [View Article][PubMed]
    [Google Scholar]
  38. Veeh R. H., Shirtliff M. E., Petik J. R., Flood J. A., Davis C. C., Seymour J. L., Hansmann M. A., Kerr K. M., Pasmore M. E., Costerton J. W. 2003; Detection of Staphylococcus aureus biofilm on tampons and menses components. J Infect Dis 188:519–530 [View Article][PubMed]
    [Google Scholar]
  39. Webster P., Wu S., Webster S., Rich K. A., McDonald K. 2004; Ultrastructural preservation of biofilms formed by non-typeable Hemophilus influenzae . Biofilms 1:165–182 [View Article]
    [Google Scholar]
  40. Witkin S. S., Linhares I. M., Giraldo P. 2007; Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol 21:347–354 [View Article][PubMed]
    [Google Scholar]
  41. Yoo J. W., Lee C. H. 2006; Drug delivery systems for hormone therapy. J Control Release 112:1–14 [View Article][PubMed]
    [Google Scholar]
  42. Yu R. R., Cheng A. T., Lagenaur L. A., Huang W. J., Weiss D. E., Treece J., Sanders-Beer B. E., Hamer D. H., Lee P. P. et al. 2009; A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development. J Med Primatol 38:125–136 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.028225-0
Loading
/content/journal/jmm/10.1099/jmm.0.028225-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error